Adult ambulatory surgical care is
provided in the OHSU DayStay facilities (consisting of
the Preadmission Testing Clinic, operating rooms,
Gastroenterology Lab, Post Anesthesia Care Unit, and
Short Stay Unit) and at OHSU Casey Eye Institute.
DayStay is attached to the main hospital but enjoys
significant autonomy and is striving to create a
patient/customer friendly atmosphere more characteristic
of a stand-alone surgical center than a Level 1 Trauma
Center. We focus on quality of surgical, anesthesia, and
nursing care, rapid turn around time, and minimum
waiting room time. DayStay is highly integrated with our
nursing staff multi-tasking across the facility.
Adult Day Stay Surgery
Over 3,500 procedures were performed in 7 DayStay
operating rooms this past year. Currently two operating
rooms feature most advanced imaging capacity [Minimally
Invasive Surgery (MIS) Suites]. We are planning on
upgrading several more rooms to the MIS standard in the
near future. The numbers of ambulatory procedures are
expected to grow at the current rate of 10-15% annually.
Ambulatory anesthesia in DayStay embraces the SAFE
(Short Acting, Fast Emergence) concept. Short acting
anesthetic agents, BIS monitoring and use of regional
anesthesia techniques facilitates bypassing of Phase 1
recovery (Fast Track concept) or significant decrease of
Phase 1 recovery time.
The Short Stay Unit integrates post surgical and post
procedure care for patients with organ transplants
requiring multiple biopsies and patients recovering from
endoscopic procedures.
Requirements for rapid turn over times in the ambulatory
setting necessitate extensive use of modern information
technology. Currently, the pre-admission evaluation
process is supported by a network based software
application capable of accessing all information
available on any patient across the entire OHSU
Healthcare System. Results of other tests and studies
are now also available over the network.
DayStay is outcomes driven. Our recovery room nurses
call all patients on the postoperative day 1 and patient
responses are entered into database according to
protocol. We also perform continuous survey of patient
satisfaction using conventional questionnaire tools.
A number of clinical research projects are being
conducted in the outpatient surgery suites. Drs. Zornow
and Kirsch have recently initiated a phase III trial of
a novel reversal agent for non-depolarizing
neuromuscular blocking agents. This agent has the
potential to quickly reverse profound levels of muscle
relaxation in surgical patients with a minimum of side
effects. Additional studies in progress include the use
of continuous infusions of local anesthetics for
postoperative pain control in ambulatory patients having
upper or lower extremity orthopedic procedures.
The GI Lab performs between 20 and 30 procedures per
day. Our most recent addition is an advanced Endoscopic
Ultrasound System for diagnosis of primarily
gastrointestinal malignancies. We have recently
established anesthesia supported deep sedation/general
anesthesia service for all ERCP procedures.
Mark Zornow, Professor
Administrative Director, Ambulatory Surgical
Services